Massive congratulations to Dr Natalie Francis from the Manchester Adult Cystic Fibrosis Centre for publishing a Cochrane Review on 'Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis'.
The review identified the need for a well designed and adequately powered randomised controlled trial to assess the efficacy and possible adverse effects of antifungal therapies for ABPA in those with CF.
Well done Natalie!